Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PneumoLabs is a specialized Contract Research Organization (CRO) based in the United Kingdom that focuses exclusively on respiratory clinical research. The company provides a comprehensive suite of services for Phase I through Phase IV clinical trials, including patient recruitment, clinical monitoring, and advanced respiratory function testing. Operating from a dedicated clinical research facility, PneumoLabs supports pharmaceutical and biotech clients in the development of treatments for conditions such as asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. Their technical capabilities include specialized diagnostics like spirometry, plethysmography, and bronchial challenge testing. By focusing solely on the respiratory niche, the company offers high-level expertise and high-quality data collection for pulmonary drug development. The organization is led by experienced clinicians and researchers with deep roots in respiratory medicine.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pneumolabs.